Updated on 31 August 2026
誉丰堂AI社区合伙人大药房项目
世界晋商总会主席、香港誉丰堂集团公司董事长 at 誉丰堂医药控股有限公司
China (Hong Kong)
About
项目由李振环发起:
李振环,男,1974年10月生,山西临县人,天津大学经济管理学院工商管理硕士,长期旅居香港,香港誉丰堂健康产业集团有限公司、誉丰堂医药集团控股董事长。
2006年成立广东誉丰堂健康产业有限公司,2013年李振环收购香港誉丰堂,在云南成立云南誉丰堂医药有限公司,布局大健康与医药产业,先后在美国、香港、中国广东、北京、云南、山西等十几个省市设立誉丰堂系企业,搭建医药连锁与进出口贸易业务体系。
计划三年内在中国大陆布局2000-5000家社区居民合伙人大药房,并完成港交所或大陆上市。
Project Location
- China (Hong Kong)
Project Format
- Private Project
Go Global Project
- No
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Investment / Financing Discussion
Main Project Sector
- Technology
Technology
- Bio-Tech
- Health Technology
- Medical Technology
Total Project Value
- 10,000,001 to 25,000,000 USD
Investment Capital Required
- 10,000,001 to 25,000,000 USD
Interested Format of Cooperation
- Convertible Loan
- Direct Equity Investment
- Equal Shareholdings
- Majority Shareholdings
Preferred Financing Model
- Equity
Type(s) of Last Financing Round of the project (if Applicable)
- Venture Capital (VC)
Return on Investment
1000%-5000%
Main Service(s) Required
- Financial Services
Financial Services
- Institutional Investment
- Islamic Finance
- Private Equity & Venture Capital
- Syndicated Loans
Similar opportunities
Project
- Yes
- Yes
- Technology
- Construction
- Private Project
- Convertible Loan
- Professional Services
- Information Technology Services
南希 田
董事长 at 湖北东信药业有限公司
China
Project
《国医百科网》 《央视聚焦》 《中国医疗新闻网》以上三家官网在播李丹萍,谢谢你了解一下?
- Yes
- Yes
- Manufacturing
- Bootstrapping
- Private Project
- Contract Drafting
- Professional Services
李士丰 李
董事长 at 中医从业者
China
Investment Target
- Equal Shareholdings
- Open for Negotiation
- Minority Shareholdings
- Direct Equity Investment
- Public–private partnership / Concession
爱军 周
CEO at DKE Holding Company Limited
China